IART
USDIntegra LifeSciences Holdings Corporation Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.390
High
$11.600
Low
$11.220
Volume
0.19M
Company Fundamentals
Market Cap
880.2M
Industry
Medical devices
Country
United States
Trading Stats
Avg Volume
1.22M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.
Integra LifeSciences Reports Third Quarter 2025 Financial Results
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.